China Pharma Holdings

China Pharma Holdings is a China-focused specialty pharmaceutical company listed on NYSE American that develops, manufactures, and markets pharmaceutical and healthcare products through its operating subsidiary in Hainan. The company has historically sold a diversified portfolio of generic and branded generic products targeting high-incidence diseases in China, including cardiovascular, central nervous system, infectious, and digestive conditions. Its manufacturing base supports multiple dosage forms such as dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. More recently, the company has also expanded into adjacent healthcare products and devices, including a dry eye disease therapeutic device and protective-mask products. The operating business is conducted primarily through Hainan Helpson Medical & Biotechnology Co., Ltd., which is wholly owned through an intermediate holding company.